BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

578 related articles for article (PubMed ID: 20708850)

  • 1. Potential of adaptive radiotherapy to escalate the radiation dose in combined radiochemotherapy for locally advanced non-small cell lung cancer.
    Guckenberger M; Wilbert J; Richter A; Baier K; Flentje M
    Int J Radiat Oncol Biol Phys; 2011 Mar; 79(3):901-8. PubMed ID: 20708850
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adaptive radiotherapy for locally advanced non-small-cell lung cancer does not underdose the microscopic disease and has the potential to increase tumor control.
    Guckenberger M; Richter A; Wilbert J; Flentje M; Partridge M
    Int J Radiat Oncol Biol Phys; 2011 Nov; 81(4):e275-82. PubMed ID: 21497450
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Concurrent radiochemotherapy with vinorelbine plus cisplatin or carboplatin in patients with locally advanced non-small-cell lung cancer (NSCLC) and an increased risk of treatment complications. Preliminary results.
    Semrau S; Bier A; Thierbach U; Virchow C; Ketterer P; Fietkau R
    Strahlenther Onkol; 2003 Dec; 179(12):823-31. PubMed ID: 14652671
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Additional PET/CT in week 5-6 of radiotherapy for patients with stage III non-small cell lung cancer as a means of dose escalation planning?
    Gillham C; Zips D; Pönisch F; Evers C; Enghardt W; Abolmaali N; Zöphel K; Appold S; Hölscher T; Steinbach J; Kotzerke J; Herrmann T; Baumann M
    Radiother Oncol; 2008 Sep; 88(3):335-41. PubMed ID: 18514339
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of adaptive treatment planning for patients with non-small cell lung cancer.
    Zhong H; Siddiqui SM; Movsas B; Chetty IJ
    Phys Med Biol; 2017 Jun; 62(11):4346-4360. PubMed ID: 28072395
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intensity-modulated radiotherapy for locally advanced non-small-cell lung cancer: a dose-escalation planning study.
    Lievens Y; Nulens A; Gaber MA; Defraene G; De Wever W; Stroobants S; Van den Heuvel F;
    Int J Radiat Oncol Biol Phys; 2011 May; 80(1):306-13. PubMed ID: 20888706
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Potential for reduced toxicity and dose escalation in the treatment of inoperable non-small-cell lung cancer: a comparison of intensity-modulated radiation therapy (IMRT), 3D conformal radiation, and elective nodal irradiation.
    Grills IS; Yan D; Martinez AA; Vicini FA; Wong JW; Kestin LL
    Int J Radiat Oncol Biol Phys; 2003 Nov; 57(3):875-90. PubMed ID: 14529795
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combining advanced radiotherapy technologies to maximize safety and tumor control probability in stage III non-small cell lung cancer.
    Guckenberger M; Kavanagh A; Partridge M
    Strahlenther Onkol; 2012 Oct; 188(10):894-900. PubMed ID: 22933031
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Phase II study of synchronous three-dimensional conformal boost to the gross tumor volume for patients with unresectable Stage III non-small-cell lung cancer: results of Korean Radiation Oncology Group 0301 study.
    Cho KH; Ahn SJ; Pyo HR; Kim KS; Kim YC; Moon SH; Han JY; Kim HT; Koom WS; Lee JS
    Int J Radiat Oncol Biol Phys; 2009 Aug; 74(5):1397-404. PubMed ID: 19117690
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of anisotropic aperture based intensity modulated radiotherapy with 3D-conformal radiotherapy for the treatment of large lung tumors.
    Simeonova A; Abo-Madyan Y; El-Haddad M; Welzel G; Polednik M; Boggula R; Wenz F; Lohr F
    Radiother Oncol; 2012 Feb; 102(2):268-73. PubMed ID: 22100654
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Impact of PET/CT on precise radiotherapy planning for non-small cell lung cancer].
    Gong HY; Yu JM; Fu Z; Li BS; Li JB; Liu TH
    Zhonghua Zhong Liu Za Zhi; 2006 Jan; 28(1):54-7. PubMed ID: 16737623
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of computed tomography and 18F-deoxyglucose coincidence detection emission tomography image fusion for optimization of conformal radiotherapy in non-small-cell lung cancer.
    Deniaud-Alexandre E; Touboul E; Lerouge D; Grahek D; Foulquier JN; Petegnief Y; Grès B; El Balaa H; Keraudy K; Kerrou K; Montravers F; Milleron B; Lebeau B; Talbot JN
    Int J Radiat Oncol Biol Phys; 2005 Dec; 63(5):1432-41. PubMed ID: 16125870
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Prognosis of locally advanced non small cell lung cancer treated with three dimentional conformal radiotherapy].
    Zhu XZ; Wang LH; Ou GF; Zhou ZM; Chen DF; Xiao ZF; Feng QF; Zhang HX; Wang M; Yin WB
    Zhonghua Zhong Liu Za Zhi; 2007 Oct; 29(10):748-53. PubMed ID: 18396686
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Feasibility of shrinking field radiation therapy through 18F-FDG PET/CT after 40 Gy for stage III non-small cell lung cancers.
    Ding XP; Zhang J; Li BS; Li HS; Wang ZT; Yi Y; Sun HF; Wang DQ
    Asian Pac J Cancer Prev; 2012; 13(1):319-23. PubMed ID: 22502693
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Daily cone-beam computed tomography used to determine tumour shrinkage and localisation in lung cancer patients.
    Knap MM; Hoffmann L; Nordsmark M; Vestergaard A
    Acta Oncol; 2010 Oct; 49(7):1077-84. PubMed ID: 20831499
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A planning study of radiotherapy dose escalation of PET-active tumour volumes in non-small cell lung cancer patients.
    Møller DS; Khalil AA; Knap MM; Muren LP; Hoffmann L
    Acta Oncol; 2011 Aug; 50(6):883-8. PubMed ID: 21767188
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A study of the anatomic changes and dosimetric consequences in adaptive CRT of non-small-cell lung cancer using deformable CT and CBCT image registration.
    Ma C; Hou Y; Li H; Li D; Zhang Y; Chen S; Yin Y
    Technol Cancer Res Treat; 2014 Apr; 13(2):95-100. PubMed ID: 23919391
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lung sparing and dose escalation in a robust-inspired IMRT planning method for lung radiotherapy that accounts for intrafraction motion.
    McCann C; Purdie T; Hope A; Bezjak A; Bissonnette JP
    Med Phys; 2013 Jun; 40(6):061705. PubMed ID: 23718584
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dosimetric analysis of the patterns of local failure observed in patients with locally advanced non-small cell lung cancer treated with neoadjuvant chemotherapy and concurrent conformal (3D-CRT) chemoradiation.
    Moreno-Jiménez M; Aristu J; López-Picazo JM; Ramos LI; Gúrpide A; Gómez-Iturriaga A; Valero J; Martínez-Monge R
    Radiother Oncol; 2008 Sep; 88(3):342-50. PubMed ID: 18558448
    [TBL] [Abstract][Full Text] [Related]  

  • 20. IMRT and 3D conformal radiotherapy with or without elective nodal irradiation in locally advanced NSCLC: A direct comparison of PET-based treatment planning.
    Fleckenstein J; Kremp K; Kremp S; Palm J; Rübe C
    Strahlenther Onkol; 2016 Feb; 192(2):75-82. PubMed ID: 26438071
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 29.